<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<pubmed-document>
<record>
<header>
<identifier>11438875</identifier>
<setSpec>0365-6691</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:author>Melcon Sánchez, B</dc:author>
<dc:author>Ferrer Novella, E</dc:author>
<dc:author>Arazo Garcés, P</dc:author>
<dc:author>Honrubia López, F M</dc:author>
<dc:author>Torrón Fernández, C</dc:author>
<dc:author>Moreno Ruiz, O</dc:author>
<dc:description xml:lang="en">PURPOSE A study of protease inhibitors on CMV retinitis in HIV infected hospital patients. METHOD A retrospective study was performed in 485 diagnosed of AIDS, between January, 1990 and December 1998. Among those, 81 patients who were diagnosed of CMV retinitis, the following was studied: anti-retroviral treatment, anti CMV treatment, survival time and CD4 lymphocyte count. RESULTS Treatment with protease inhibitors in HIV patients showed an increase in life expectancy, reduced the incidence of CMV retinitis and a reduction in CMV retinitis prevention treatment was observed. CONCLUSIONS Treatment with protease inhibitors has reduced the rate of CMV retinitis in HIV patients.</dc:description>
<dc:type>Comparative Study</dc:type>
<dc:language>es</dc:language>
<dc:date>2001 Jul </dc:date>
<dc:title xml:lang="es">Evolución de la retinitis por citomegalovirus con las diferentes terapias antirretrovirales en nuestro hospital.</dc:title>
<dc:title xml:lang="en">[Clinical course of cytomegalovirus retinitis with the different antiretroviral therapies in our hospital].</dc:title>
<dc:publisher>Archivos de la Sociedad Espanola de Oftalmologia</dc:publisher>
</metadata>
</record>
</pubmed-document>
